Page 8 - Hyperfine Inc News Today

Hyperfine, Inc. (NASDAQ:HYPR – Get Rating) Director Jonathan M. Rothberg purchased 52,848 shares of the business’s stock in a transaction that occurred on Tuesday, June 14th. The stock was acquired at an average price of $2.26 per share, for a total transaction of $119,436.48. Following the acquisition, the director now directly owns 176,508 shares of […]

GuruFocus Article or News written by GuruFocusNews and the topic is about:

Hyperfine (NASDAQ:HYPR – Get Rating) and Masimo (NASDAQ:MASI – Get Rating) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability. Volatility and Risk Hyperfine has a beta of 0.85, suggesting that its […]

Outset Medical (NASDAQ:OM – Get Rating) and Hyperfine (NASDAQ:HYPR – Get Rating) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, earnings, profitability, valuation and institutional ownership. Institutional and Insider Ownership 22.7% of Hyperfine shares are owned […]

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Hyperfine, Inc. (NASDAQ:NASDAQ:HYPR) Q1 2022 Earnings Conference Call May 11, 2022, 04:30 PM ET Company Participants Marissa Bych - Gilmartin Group IR Dave Scott - President and CEO Alok...

Chinese smart wearable devices pioneer Zepp Health Corp is ratcheting up its research and development in artificial intelligence and semiconductors as it eyes big leaps in smartwatch technologies.

/PRNewswire/ -- In 2021, the global brain modalities and software market was valued at $13,343.3 million, which is set to reach $23,195.6 million by 2030, at a...

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

In this article, we’ll check out the top 9 stocks billionaire Larry Robbins just added to his portfolio, which also happen to be the only nine stocks added to his portfolio during Q4.